Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Oncology Injection Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Oncology Injection Drug Market Overview

    • 1.1 Product Overview and Scope of Oncology Injection Drug
    • 1.2 Oncology Injection Drug Segment by Type
      • 1.2.1 Global Oncology Injection Drug Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Organs
      • 1.2.3 Central Nervous System
      • 1.2.4 Circulatory/Musculoskeletal System
    • 1.3 Oncology Injection Drug Segment by Application
      • 1.3.1 Oncology Injection Drug Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Lymphoma
      • 1.3.3 Myeloma
      • 1.3.4 Prostate Cancer
    • 1.4 Global Oncology Injection Drug Market Size Estimates and Forecasts
      • 1.4.1 Global Oncology Injection Drug Revenue 2015-2026
      • 1.4.2 Global Oncology Injection Drug Sales 2015-2026
      • 1.4.3 Oncology Injection Drug Market Size by Region: 2020 Versus 2026

    2 Global Oncology Injection Drug Market Competition by Manufacturers

    • 2.1 Global Oncology Injection Drug Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Oncology Injection Drug Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Oncology Injection Drug Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Oncology Injection Drug Manufacturing Sites, Area Served, Product Type
    • 2.5 Oncology Injection Drug Market Competitive Situation and Trends
      • 2.5.1 Oncology Injection Drug Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Oncology Injection Drug Players (Opinion Leaders)

    3 Oncology Injection Drug Retrospective Market Scenario by Region

    • 3.1 Global Oncology Injection Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Oncology Injection Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Oncology Injection Drug Market Facts & Figures by Country
      • 3.3.1 North America Oncology Injection Drug Sales by Country
      • 3.3.2 North America Oncology Injection Drug Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Oncology Injection Drug Market Facts & Figures by Country
      • 3.4.1 Europe Oncology Injection Drug Sales by Country
      • 3.4.2 Europe Oncology Injection Drug Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Oncology Injection Drug Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Oncology Injection Drug Sales by Region
      • 3.5.2 Asia Pacific Oncology Injection Drug Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Oncology Injection Drug Market Facts & Figures by Country
      • 3.6.1 Latin America Oncology Injection Drug Sales by Country
      • 3.6.2 Latin America Oncology Injection Drug Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Oncology Injection Drug Sales by Country
      • 3.7.2 Middle East and Africa Oncology Injection Drug Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Oncology Injection Drug Historic Market Analysis by Type

    • 4.1 Global Oncology Injection Drug Sales Market Share by Type (2015-2020)
    • 4.2 Global Oncology Injection Drug Revenue Market Share by Type (2015-2020)
    • 4.3 Global Oncology Injection Drug Price Market Share by Type (2015-2020)
    • 4.4 Global Oncology Injection Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Oncology Injection Drug Historic Market Analysis by Application

    • 5.1 Global Oncology Injection Drug Sales Market Share by Application (2015-2020)
    • 5.2 Global Oncology Injection Drug Revenue Market Share by Application (2015-2020)
    • 5.3 Global Oncology Injection Drug Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Oncology Injection Drug Business

    • 6.1 Taj Oncology
      • 6.1.1 Corporation Information
      • 6.1.2 Taj Oncology Description, Business Overview and Total Revenue
      • 6.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Taj Oncology Products Offered
      • 6.1.5 Taj Oncology Recent Development
    • 6.2 S.G. Biopharm
      • 6.2.1 S.G. Biopharm Oncology Injection Drug Production Sites and Area Served
      • 6.2.2 S.G. Biopharm Description, Business Overview and Total Revenue
      • 6.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 S.G. Biopharm Products Offered
      • 6.2.5 S.G. Biopharm Recent Development
    • 6.3 AdvaCare
      • 6.3.1 AdvaCare Oncology Injection Drug Production Sites and Area Served
      • 6.3.2 AdvaCare Description, Business Overview and Total Revenue
      • 6.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 AdvaCare Products Offered
      • 6.3.5 AdvaCare Recent Development
    • 6.4 Merrimack
      • 6.4.1 Merrimack Oncology Injection Drug Production Sites and Area Served
      • 6.4.2 Merrimack Description, Business Overview and Total Revenue
      • 6.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Merrimack Products Offered
      • 6.4.5 Merrimack Recent Development
    • 6.5 Celgene
      • 6.5.1 Celgene Oncology Injection Drug Production Sites and Area Served
      • 6.5.2 Celgene Description, Business Overview and Total Revenue
      • 6.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Celgene Products Offered
      • 6.5.5 Celgene Recent Development
    • 6.6 Allos Therapeutics
      • 6.6.1 Allos Therapeutics Oncology Injection Drug Production Sites and Area Served
      • 6.6.2 Allos Therapeutics Description, Business Overview and Total Revenue
      • 6.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Allos Therapeutics Products Offered
      • 6.6.5 Allos Therapeutics Recent Development
    • 6.7 Ferring Pharmaceuticals
      • 6.6.1 Ferring Pharmaceuticals Oncology Injection Drug Production Sites and Area Served
      • 6.6.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
      • 6.6.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Ferring Pharmaceuticals Products Offered
      • 6.7.5 Ferring Pharmaceuticals Recent Development
    • 6.8 Genzyme
      • 6.8.1 Genzyme Oncology Injection Drug Production Sites and Area Served
      • 6.8.2 Genzyme Description, Business Overview and Total Revenue
      • 6.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Genzyme Products Offered
      • 6.8.5 Genzyme Recent Development
    • 6.9 Eli Lilly
      • 6.9.1 Eli Lilly Oncology Injection Drug Production Sites and Area Served
      • 6.9.2 Eli Lilly Description, Business Overview and Total Revenue
      • 6.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Eli Lilly Products Offered
      • 6.9.5 Eli Lilly Recent Development
    • 6.10 Praecis Pharmaceuticals
      • 6.10.1 Praecis Pharmaceuticals Oncology Injection Drug Production Sites and Area Served
      • 6.10.2 Praecis Pharmaceuticals Description, Business Overview and Total Revenue
      • 6.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Praecis Pharmaceuticals Products Offered
      • 6.10.5 Praecis Pharmaceuticals Recent Development
    • 6.11 Millennium Pharmaceuticals
      • 6.11.1 Millennium Pharmaceuticals Oncology Injection Drug Production Sites and Area Served
      • 6.11.2 Millennium Pharmaceuticals Oncology Injection Drug Description, Business Overview and Total Revenue
      • 6.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Millennium Pharmaceuticals Products Offered
      • 6.11.5 Millennium Pharmaceuticals Recent Development
    • 6.12 Debiopharm
      • 6.12.1 Debiopharm Oncology Injection Drug Production Sites and Area Served
      • 6.12.2 Debiopharm Oncology Injection Drug Description, Business Overview and Total Revenue
      • 6.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Debiopharm Products Offered
      • 6.12.5 Debiopharm Recent Development
    • 6.13 Alza
      • 6.13.1 Alza Oncology Injection Drug Production Sites and Area Served
      • 6.13.2 Alza Oncology Injection Drug Description, Business Overview and Total Revenue
      • 6.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Alza Products Offered
      • 6.13.5 Alza Recent Development
    • 6.14 CordenPharma
      • 6.14.1 CordenPharma Oncology Injection Drug Production Sites and Area Served
      • 6.14.2 CordenPharma Oncology Injection Drug Description, Business Overview and Total Revenue
      • 6.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 CordenPharma Products Offered
      • 6.14.5 CordenPharma Recent Development
    • 6.15 Pharmascience
      • 6.15.1 Pharmascience Oncology Injection Drug Production Sites and Area Served
      • 6.15.2 Pharmascience Oncology Injection Drug Description, Business Overview and Total Revenue
      • 6.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 Pharmascience Products Offered
      • 6.15.5 Pharmascience Recent Development

    7 Oncology Injection Drug Manufacturing Cost Analysis

    • 7.1 Oncology Injection Drug Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Oncology Injection Drug
    • 7.4 Oncology Injection Drug Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Oncology Injection Drug Distributors List
    • 8.3 Oncology Injection Drug Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Oncology Injection Drug Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Oncology Injection Drug by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Oncology Injection Drug by Type (2021-2026)
    • 10.2 Oncology Injection Drug Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Oncology Injection Drug by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Oncology Injection Drug by Application (2021-2026)
    • 10.3 Oncology Injection Drug Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Oncology Injection Drug by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Oncology Injection Drug by Region (2021-2026)
    • 10.4 North America Oncology Injection Drug Estimates and Projections (2021-2026)
    • 10.5 Europe Oncology Injection Drug Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Oncology Injection Drug Estimates and Projections (2021-2026)
    • 10.7 Latin America Oncology Injection Drug Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Oncology Injection Drug Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Oncology Injection Drug market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on Oncology Injection Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oncology Injection Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Oncology Injection Drug market is segmented into
      Organs
      Central Nervous System
      Circulatory/Musculoskeletal System

      Segment by Application
      Lymphoma
      Myeloma
      Prostate Cancer

      Global Oncology Injection Drug Market: Regional Analysis
      The Oncology Injection Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Oncology Injection Drug market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Oncology Injection Drug Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Oncology Injection Drug market include:
      Taj Oncology
      S.G. Biopharm
      AdvaCare
      Merrimack
      Celgene
      Allos Therapeutics
      Ferring Pharmaceuticals
      Genzyme
      Eli Lilly
      Praecis Pharmaceuticals
      Millennium Pharmaceuticals
      Debiopharm
      Alza
      CordenPharma
      Pharmascience

      Buy now